Furthermore, the pharmacological inhibition of IL-1 signaling by administration of recombinant human IL-1Ra to DIO mice attenuated obesity-induced hepatic steatosis and reduced hepatic lipogenic gene expression. The gene discussed is IL1B; the disease is Hepatic steatosis.